Drug Shortage Report for APTIOM
Report ID | 227211 |
Drug Identification Number | 02426862 |
Brand name | APTIOM |
Common or Proper name | eslicarbazepine acetate tablets |
Company Name | SUMITOMO PHARMA CANADA, INC. |
Market Status | MARKETED |
Active Ingredient(s) | ESLICARBAZEPINE ACETATE |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Bottle of 30 |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-06-07 |
Actual start date | |
Estimated end date | 2024-07-07 |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2024-05-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7025 LANGER DRIVE MISSISSAUGA, ONTARIO CANADA L5N 0E8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-05-07 | French | Compare |
v1 | 2024-05-07 | English | Compare |
Showing 1 to 2 of 2